All Stories

  1. The Physical and Psychological Benefits of Nordic Walking in Patients with Breast Cancer: A Systematic Review
  2. Metabolic Syndrome Is Associated with Increased Plasma Fibroblast Growth Factor 21 (FGF21) in Postmenopausal Breast Cancer Survivors: Implications for Therapy and Diagnosis
  3. Plasma Estrone Concentration Is Associated with Physical Activity Levels in Postmenopausal Breast Cancer Survivors
  4. Health‐Related Quality of Life Among Patients With Ostomy Intestinal Stoma According to Sex and Ostomy Permanence: A Systematic Review and Meta‐Analysis
  5. Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis
  6. Association Between Mediterranean Diet Consumption and the Physical and Mental Components of HRQL in Community-Dwelling Older Adults in Valencia
  7. Abstracts from the 1st International Online Conference on Diseases
  8. Association Between Sleep Disturbance and Behavioral Feeding Problems in Children and Adolescents with Autism Spectrum Disorder
  9. Fallskip® Parameters and Their Relationship with the Risk of Falls in Older Individuals with and Without Diabetes
  10. Analysis of the Association Between Symptoms of Inattention and Hyperactivity–Impulsivity and Substance Abuse in University Students
  11. The Associations Between Chronotype and Mental Health in Nursing Students
  12. Salivary 1,5-Anhydroglucitol and AGEs Are Associated with Postural Instability in Diabetic Foot Patients
  13. Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages—A Systematic Review and Meta-Analysis
  14. Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis
  15. Plasma IL-1β Concentration Associates with Sleep Quality and Cognitive Functions in Men with Prostate Cancer
  16. Non-Pharmacological Interventions for Managing the Symptoms of Depression in Women with Breast Cancer: A Literature Review of Clinical Trials
  17. Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors
  18. Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease
  19. The Long-Lasting Effect of Multidisciplinary Interventions for Emotional and Social Loneliness in Older Community-Dwelling Individuals: A Systematic Review
  20. Social and Mental Health Factors Involved in the Severity of Loneliness in Older Individuals in a Spanish Rural Area
  21. Impact of a Physical Exercise and Health Education Program on Metabolic Syndrome and Quality of Life in Postmenopausal Breast Cancer Women Undergoing Adjuvant Treatment with Aromatase Inhibitors
  22. Long-Term Caregiving Impact and Self-Care Strategies in Family Caregivers of People with Neuropsychiatric Disorders: A Mixed-Method Study
  23. Salivary IL-1 Beta Level Associated with Poor Sleep Quality in Children/Adolescents with Autism Spectrum Disorder
  24. Effect of a Physical Exercise Intervention on Physical Function Parameters and Blood Analytical Changes in Lung Cancer Survivors: A Feasibility Study
  25. Association between Hand Hygiene Knowledge and Self-Efficacy in Nursing Students: A Multicenter Cross-Sectional Study within the Framework of the Erasmus Project
  26. Autistic Children/Adolescents Have Lower Adherence to the Mediterranean Diet and Higher Salivary IL-6 Concentration: Potential Diet–Inflammation Links?
  27. Factors Affecting Sleep Quality among University Medical and Nursing Students: A Study in Two Countries in the Mediterranean Region
  28. The Association between Functional Health Patterns and Frailty in Hospitalized Geriatric Patients
  29. Salivary Brain-Derived Neurotrophic Factor and Cortisol Associated with Psychological Alterations in University Students
  30. Inflammatory Biomarkers and Gait Impairment in Older Adults: A Systematic Review
  31. Psychological Alterations in Youths with Type I Diabetes: Associations with Salivary Cortisol Concentration
  32. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy
  33. Wearable sensors-based postural analysis and fall risk assessment among patients with diabetic foot neuropathy
  34. Can Leucine Supplementation Improve Frailty Index Scores?
  35. Increased Salivary IL-1 Beta Level Is Associated with Poor Sleep Quality in University Students
  36. Evaluating video virtual reality teaching for nursing students
  37. Relationship between Cognitive Impairment and Depressive Symptoms with Somatosensory Functions in Diabetic and Non-Diabetic Older Adults and Its Impact on Quality of Life
  38. Association between Depressive Symptoms and Adherence to the Mediterranean Diet in Nursing Students
  39. Actigraphy Analysis of Sleep Associates with Salivary IL-6 Concentration in Institutionalized Older Individuals
  40. Editorial: Food-polyphenol-induced modulation of neurodegeneration
  41. Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals
  42. Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy
  43. Relationship between deep and superficial sensitivity assessments and gait analysis in diabetic foot patients
  44. Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review
  45. Social and Emotional Loneliness in Older Community Dwelling-Individuals: The Role of Socio-Demographics
  46. The Effects of 3D Custom Foot Orthotics with Mechanical Plantar Stimulation in Older Individuals with Cognitive Impairment: A Pilot Study
  47. Mediterranean Diet Adherence in Community-Dwelling Older Adults in Spain: Social Determinants Related to the Family
  48. Perceived mental health and emotional trajectories of long-term family caregivers of persons with mental conditions: A mixed-methods study
  49. Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
  50. The Effects of Probiotics and Prebiotics on Gastrointestinal and Behavioural Symptoms in Autism Spectrum Disorder
  51. Respiratory Function Correlates with Fat Mass Index and Blood Triglycerides in Institutionalized Older Individuals
  52. Salivary Biomarkers Associated with Psychological Alterations in Patients with Diabetes: A Systematic Review
  53. Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
  54. Plasma Nickel Levels Correlate with Low Muscular Strength and Renal Function Parameters in Patients with Prostate Cancer
  55. Foot Orthosis and Sensorized House Slipper by 3D Printing
  56. Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials
  57. Knowledge and Attitudes towards Palliative Care: Validation of the Spanish Version of Questionnaire on Palliative Care for Advanced Dementia
  58. Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer
  59. Salivary IL-6 Concentration Is Associated with Frailty Syndrome in Older Individuals
  60. Personal and Social Consequences of Psychotropic Substance Use: A Population-Based Internet Survey
  61. Prenatal exposure to phthalates and its effects upon cognitive and motor functions: A systematic review
  62. Wearable Sensor for Assessing Gait and Postural Alterations in Patients with Diabetes: A Scoping Review
  63. Circadian Rhythm and Concentration of Melatonin in Breast Cancer Patients
  64. Cognitive Functions under Anti-HER2 Targeted Therapy in Cancer Patients: A Scoping Review
  65. Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review
  66. Lymphocytes as a Biomarker of Frailty Syndrome: A Scoping Review
  67. Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
  68. Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review
  69. Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study
  70. Special Issue “Mental Health Issues and Quality of Life in Older Individuals”
  71. Changes in Salivary Amylase and Glucose in Diabetes: A Scoping Review
  72. Salivary Inflammatory Molecules as Biomarkers of Sleep Alterations: A Scoping Review
  73. Weight Loss and Improvement of Metabolic Alterations in Overweight and Obese Children Through the I2AO2 Family Program: A Randomized Controlled Clinical Trial
  74. Hair Cortisol Concentration as a Biomarker of Sleep Quality and Related Disorders
  75. Effects of Probiotics in the Management of Infected Chronic Wounds: From Cell Culture to Human Studies
  76. New Effects of Prebiotics, Probiotics, and Symbiotics
  77. The Association between Cognitive Impairment and Diabetic Foot Care: Role of Neuropathy and Glycated Hemoglobin
  78. Salivary Stress/Immunological Markers in Crohn’s Disease and Ulcerative Colitis
  79. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children: The Role of Family-Related Social Determinants
  80. Immune Alterations in Frailty Syndrome and Cognitive Impairment
  81. Quality of Life in Individuals with Diabetic Foot Syndrome
  82. The Association between Peripheral Blood Cells and the Frailty Syndrome in Patients with Cardiovascular Diseases
  83. Neurotransmitters and Behavioral Alterations Induced by Nickel Exposure
  84. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing
  85. Respiratory Muscle Strengths and Their Association with Lean Mass and Handgrip Strengths in Older Institutionalized Individuals
  86. Therapeutic potential of alkaloids in autoimmune diseases: Promising candidates for clinical trials
  87. Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy
  88. Mechanical Plantar Foot Stimulation in Parkinson′s Disease: A Scoping Review
  89. Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial
  90. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects
  91. Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review
  92. Beneficial Effect of Foot Plantar Stimulation in Gait Parameters in Individuals with Parkinson’s Disease
  93. Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings
  94. Sleep quality and its association with substance abuse among university students
  95. Neuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome
  96. Alcohol and Drug Use in European University Health Science Students: Relationship with Self-Care Ability
  97. Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy
  98. Sleep assessment devices: types, market analysis, and a critical view on accuracy and validation
  99. Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies
  100. Decrease in Serum Vitamin D Level of Older Patients with Fatigue
  101. Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review
  102. Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders
  103. Alcohol and Cannabis Intake in Nursing Students
  104. Neuro-Psychiatric Disorders: From Diagnosis to Care
  105. First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder
  106. Delay in the Diagnosis of Breast and Colorectal Cancer in People With Severe Mental Disorders
  107. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children with Attention Deficit and Hyperactivity Disorder
  108. Relationship between mobility and cognitive impairment in patients with Alzheimer’s disease
  109. Skeletal alterations, developmental delay and new mutations in juvenile-onset Pompe disease
  110. Quality of Life in People with Coeliac Disease: Psychological and Socio- Economic Aspects
  111. Subjective neurocognition and quality of life in patients with bipolar disorder and siblings
  112. Can a Prebiotic Formulation Reduce Frailty Levels in Older People?
  113. Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease
  114. Staging, Neurocognition and Social Functioning in Bipolar Disorder
  115. Cognitive impairment associated with chronic lead exposure in adults
  116. Interventions aimed to increase independence and well-being in patients with Alzheimer’s disease: Review of some interventions in the Italian context
  117. Quality of life related to clinical features in patients with Rett syndrome and their parents: a systematic review
  118. Blood zinc levels and cognitive and functional evaluation in non-demented older patients
  119. Homocysteine Levels in Autism Spectrum Disorder: A Clinical Update
  120. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders
  121. Editorial: Metabolic and Hormonal Alterations in Neuro-Psychiatric Disorders
  122. A survey on sleep assessment methods
  123. Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroinflammation and the l -arginine-nitric oxide pathway
  124. Subjective and objective sleep quality in elderly individuals: The role of psychogeriatric evaluation
  125. Frailty and leucocyte count are predictors of all-cause mortality and hospitalization length in non-demented institutionalized older women
  126. A survey on sleep questionnaires and diaries
  127. Febrile seizure and related syndromes
  128. The Effect of Moderate- Versus High-Intensity Resistance Training on Systemic Redox State and DNA Damage in Healthy Older Women
  129. Non-pharmacological interventions in patients with spinal cord compression: a systematic review
  130. Blood Infusion and the Risk of Haemorrhage in Patients Undergoing Cardiac Surgery with Extracorporeal Circulation
  131. Clinical staging and serum cytokines in bipolar patients during euthymia
  132. The effect of probiotics as a treatment for constipation in elderly people: A systematic review
  133. Research in Medical–Surgical Nursing
  134. Sleep Alterations in Non-demented Older Individuals: The Role of Cortisol
  135. Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders
  136. Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial
  137. Serum vitamin D and functional impairment in octogenarian women
  138. Brain-derived neurotrophic factor correlates with functional and cognitive impairment in non-disabled older individuals
  139. Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes
  140. Frailty syndrome and pre-operative risk evaluation: A systematic review
  141. Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder
  142. Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital
  143. Lead Excretion in Spanish Children with Autism Spectrum Disorder
  144. Autism and Intellectual Disability Associated with Mitochondrial Disease and Hyperlactacidemia
  145. The relationship between depression and frailty syndrome: a systematic review
  146. Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat model
  147. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
  148. Clinical features of prefrail older individuals and emerging peripheral biomarkers: A systematic review
  149. The value of neutrophil and lymphocyte count in frail older women
  150. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists
  151. Interleukin 6 and cognitive dysfunction
  152. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests
  153. Blocking NMDA Receptors Delays Death in Rats with Acute Liver Failure by Dual Protective Mechanisms in Kidney and Brain
  154. Pregnenolone Sulfate Restores the Glutamate-Nitric-Oxide-cGMP Pathway and Extracellular GABA in Cerebellum and Learning and Motor Coordination in Hyperammonemic Rats
  155. Gender differences in Neurotoxicity
  156. Gender differential effects of developmental exposure to methyl-mercury, polychlorinated biphenyls 126 or 153, or its combinations on motor activity and coordination
  157. Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy
  158. Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain
  159. Hyperammonemia alters the modulation by different neurosteroids of the glutamate–nitric oxide–cyclic GMP pathway through NMDA‐ GABAA‐ or sigma receptors in cerebellumin vivo
  160. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex
  161. Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations
  162. Sildenafil citrate improves perinatal outcome in fetuses from pre‐eclamptic rats
  163. Alteration of serotonin system by polychlorinated biphenyls exposure
  164. Gender-dependent behavioural impairment and brain metabolites in young adult rats after short term exposure to lead acetate
  165. An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain
  166. Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models
  167. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo
  168. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts
  169. 3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
  170. Alterations of apparent diffusion coefficient (ADC) in the brain of rats chronically exposed to lead acetate
  171. Brain Region-Selective Mechanisms Contribute to the Progression of Cerebral Alterations in Acute Liver Failure in Rats
  172. Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats
  173. Differential long-term effects of developmental exposure to polychlorinated biphenyls 52, 138 or 180 on motor activity and neurotransmission. Gender dependence and mechanisms involved
  174. Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers
  175. Hyperammonemia Induces Neuroinflammation That Contributes to Cognitive Impairment in Rats With Hepatic Encephalopathy
  176. Developmental exposure to polychlorinated biphenyls 52, 138 or 180 affects differentially learning or motor coordination in adult rats. mechanisms involved
  177. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications
  178. cGMP modulates stem cells differentiation to neurons in brain in vivo
  179. Effects of developmental exposure to different NDL–PCB congeners on cognitive and motor function. Possible underlying mechanisms. NDL–PCBs session
  180. Motor alterations induced by chronic lead exposure
  181. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: Ibuprofen restores its motor activity
  182. Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex
  183. Role of NMDA receptors in acute liver failure and ammonia toxicity: Therapeutical implications
  184. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: Therapeutical implications
  185. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy
  186. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain
  187. Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium‐calmodulin kinase II
  188. Developmental exposure to polychlorinated biphenyls or methylmercury, but not to its combination, impairs the glutamate–nitric oxide–cyclic GMP pathway and learning in 3-month-old rats
  189. Brain cholinergic impairment in liver failure
  190. Developmental exposure to polychlorinated biphenyls PCB153 or PCB126 impairs learning ability in young but not in adult rats
  191. Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors
  192. NMDA receptors in hyperammonemia and hepatic encephalopathy
  193. Hyperammonaemia alters the mechanisms by which metabotropic glutamate receptors in nucleus accumbens modulate motor function
  194. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats
  195. The function of the glutamate–nitric oxide–cGMP pathway in brain in vivo and learning ability decrease in parallel in mature compared with young rats
  196. Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts
  197. Intermittent ethanol exposure induces inflammatory brain damage and causes long‐term behavioural alterations in adolescent rats
  198. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra
  199. Sensitization to caffeine and cross-sensitization to amphetamine: Influence of individual response to caffeine
  200. Mechanisms of developmental neurotoxicity: Molecular and behavioral correlates
  201. Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia
  202. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure
  203. Altered Modulation of Motor Activity by Group I Metabotropic Glutamate Receptors in the Nucleus Accumbens in Hyperammonemic Rats
  204. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists
  205. Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function
  206. Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function
  207. Caffeine and the dopaminergic system
  208. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus
  209. Synthesis of new 2-arylamino-6-trifluoromethylpyridine-3-carboxylic acid derivatives and investigation of their analgesic activity
  210. Chronic hyperammonemia alters motor and neurochemical responses to activation of group i metabotropic glutamate receptors in the nucleus accumbens in rats in vivo
  211. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal
  212. Subchronic Caffeine Exposure Induces Sensitization to Caffeine and Cross-Sensitization to Amphetamine Ipsilateral Turning Behavior Independent from Dopamine Release
  213. Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties
  214. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D 1 and D 2 receptor agonists
  215. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic‐intermittent L‐dopa and A2A receptor blockade plus L‐Dopa in dopamine‐denervated rats
  216. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors